Research and Development Services
To support Amgen’s mission of serving patients, the R&D organization aims to discover, develop, and deliver transformative medicines that address the leading causes of death and disability, working to meet the needs of as many patients as possible. To achieve this vision, we need to take full advantage of opportunities arising from rapid scientific progress and new technologies. Biotechnology and the data sciences are advancing at blinding speed, opening up immense new possibilities. At the same time, competition within the industry is intensifying, and access hurdles to medicines are more numerous and steeper.
-
Most popular related searches
Details
To keep pace with these rapidly changing opportunities and challenges, Amgen has adopted a dynamic R&D strategy. It is designed to:
- Preserve the core elements of our legacy strategy, including a focus on large effect sizes in serious illnesses and a Biology First approach to understanding disease and designing new potential therapies.
- Guide us in making smart, well-integrated choices that reflect the world as it is today.
- Positioning us to adapt rapidly as our opportunities and challenges evolve.
Amgen’s scientific success has been rooted in a unique “triple threat” capability that includes world-class human genetics, a deep understanding of disease biology, and the molecular engineering expertise needed to design the right drug for the right target. By building on Amgen’s long-standing strengths in science and biotechnology, we’re confident we can deliver solutions that patients need and society will embrace.
Customer reviews
No reviews were found for Research and Development Services. Be the first to review!